Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment

Cellular therapy has entered the daily clinical life with the approval of CAR T cell therapeutics and dendritic cell (DCs) vaccines in the US and the EU. In addition, numerous other adoptive cellular products, including natural killer (NK) cells, are currently evaluated in early phase I/ II clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacobs, Benedikt, Gebel, Veronika, Heger, Lukas, Grèze, Victoria, Schild, Hansjörg, Dudziak, Diana, Ullrich, Evelyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160470/
https://www.ncbi.nlm.nih.gov/pubmed/34054844
http://dx.doi.org/10.3389/fimmu.2021.670540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160470/
https://www.ncbi.nlm.nih.gov/pubmed/34054844
http://dx.doi.org/10.3389/fimmu.2021.670540

Ejemplares similares